1 in 6

Couples Face Infertility in India

2.5M+

IVF Cycles Performed Annually in India

50M+

Women With PCOS in India

WHO-GMP

Certified Manufacturing

Women’s health in India is at an inflection point. Infertility rates are rising. Endometriosis remains chronically underdiagnosed. PCOS affects an estimated 1 in 5 women of reproductive age. And IVF — once considered a last resort — is now a mainstream clinical pathway sought by hundreds of thousands of couples every year.

This growing clinical demand requires a pharmaceutical partner that understands women’s health at the depth a specialist does — not just a company that lists gynaecology products in a catalogue. It requires WHO-GMP certified manufacturing, formulation expertise across hormonal therapy, fertility support, progesterone supplementation and nutritional management, and the kind of scientific credibility that gives a prescribing gynaecologist or IVF specialist the confidence to recommend a brand by name.

Quinek Life Sciences is built for exactly this clinical environment. This article explains who we are, what our gynaecology and IVF portfolio covers, and why doctors and distributors across India trust Quinek as their specialty pharma partner in women’s health.

The Gynaecology & IVF Pharma Landscape in India

India is among the largest markets for gynaecology and fertility pharmaceuticals in Asia — and one of the fastest growing. The convergence of rising infertility rates, increasing awareness of reproductive health, expanding IVF infrastructure beyond metro cities and a growing middle-class willingness to invest in fertility treatment has created significant and sustained demand for quality gynae and IVF pharmaceutical products.

Yet the market is crowded — and unevenly certified. Many companies offer gynaecology products without the manufacturing standards, formulation depth or clinical credibility that specialty prescribers require. For a gynaecologist or IVF specialist recommending a progesterone formulation or an FSH injection, the quality of what reaches the patient matters enormously.

INDIA WOMEN’S HEALTH — KEY DATA

Infertility affects approximately 10–15% of couples in India · Source: NCBI — Infertility in India
PCOS prevalence in Indian women of reproductive age: 9–22% · Source: NCBI — PCOS in India
India has over 1,400 IVF centres — among the highest globally · Source: WHO Infertility Report, 2023

Why Quality Certification Is Non-Negotiable in Women’s Health

Gynaecology and IVF pharmaceuticals are not ordinary medicines. Many are administered to pregnant women, women undergoing hormonal stimulation, or patients in the critical window of embryo implantation. The stakes of formulation inconsistency are not abstract — they are measured in failed cycles, early pregnancy losses and missed clinical windows.

Hormonal Precision

FSH, HMG and HCG formulations must deliver exact IU dosing. Variability in potency directly affects follicular response and cycle outcomes.

Progesterone Bioavailability

SR and vaginal progesterone formulations must release consistently. Inconsistent dissolution profiles cause breakthrough symptoms and threatened miscarriage.

Sterility of Injectables

Injectable gonadotropins and HCG must be manufactured under sterile conditions. Non-GMP injectables carry infection and contamination risk.

Patient Population Safety

Pregnant women and women undergoing IVF are among the most pharmacologically vulnerable patients. GMP certification is the minimum acceptable standard.

“In IVF and early pregnancy management, the formulation is part of the clinical protocol. Substandard manufacturing is not just a quality failure — it is a clinical risk to the patient and the pregnancy.”

Progesterone & Hormonal Support — Core of the Portfolio

Progesterone supplementation is the single most prescribed intervention in both IVF cycles and early pregnancy management. From luteal phase support after egg retrieval to threatened miscarriage management in spontaneous conceptions, progesterone is indispensable — and the formulation choice matters.

QUINEK PROGESTERONE & HORMONAL RANGE

QUINEK Dydrogesterone 10mg
Oral retroprogesterone · High bioavailability · Threatened & recurrent miscarriage · Luteal phase support · No sedating side effects
QGESS-200
Progesterone 200mg SR · Sustained release · First trimester support · Luteal phase maintenance · Consistent bioavailability
Momtime Gel
Progesterone Gel 8% w/w · Vaginal route · First-uterine-pass effect · IVF luteal support · Endometrial preparation
Ezi-Trone INJ
Medroxyprogesterone Acetate 150mg/ml · Injectable · High systemic levels · IVF protocols requiring IM route
ESTRAFLEG (Oral)
Estradiol Hemihydrate 2mg · Endometrial preparation in FET cycles · HRT · Oestrogen supplementation
QHIST-10 / QHIST-5
Northisterone Acetate CR 10mg / Northisterone 5mg · Menstrual regulation · Dysfunctional uterine bleeding

IVF & Fertility Range — Complete Cycle Support

Our IVF and fertility portfolio covers every phase of the assisted reproduction cycle — from ovarian stimulation and follicle development to trigger injection, endometrial preparation, luteal phase support and post-retrieval care. IVF specialists can manage the full protocol with Quinek formulations — without having to source from multiple suppliers.

IVF CYCLE PHASE — QUINEK FORMULATION MAPPING

Ovarian Stimulation

GY-Fish 75 / 150 (FSH)
Gynotrop 75 / 150 (HMG)

Trigger Injection

GY-NRH 5000
(HCG 5000 IU)

Endometrial Prep

Estrafleg Gel / Oral
AL-GRO Cream

Luteal Support

Momtime Gel · QGESS-200
Ezi-Trone INJ

Post-Retrieval Care

GYPROST 125 / 250
(Carboprost)

Gynaecology Range — Full Women’s Health Portfolio

Beyond IVF, our gynaecology portfolio addresses the full breadth of clinical needs a practising gynaecologist encounters — PCOS management, ovulation induction, endometriosis, hormonal contraception, vaginal infection, menstrual disorders, nutritional deficiencies in pregnancy and antifungal care.

QUINEK GYNAECOLOGY — FULL PORTFOLIO BY INDICATION

PCOS Management
DEE ZYR (Myo-Inositol + D-Chiro-Inositol + L-Methyl Folate + Vit D3) · QNYL-35 (Cyproterone + EE) · CYBER (Cabergoline)
Ovulation Induction
GEN-Z50 (Clomiphene 50mg) · LITRLY 2.5 / 5 (Letrozole) · AMRYO KIT (Comprehensive fertility kit)
Endometriosis
DEE-NYL (Dienogest 2mg) · DEE-NYL PLUS (Dienogest + Ethinylestradiol) · F-ibroid (Tripterygium + Green Tea + Vit D3)
Hormonal Contraception
DESONYL (Desogestrel + EE) · ROSPIRON-30 (Drospirenone + EE) · DEE-NYL PLUS
Vaginal Infections
AMY Q (Clindamycin + Clotrimazole) · MYSOF 600 (Fenticonazole 600mg)
Nutrition in Pregnancy
SIFER-XT (Iron + Folic Acid + Zinc) · SIFER-D (Folic Acid + DHA) · REFRESH TAB / REFRESH-24 (Anti-nausea + B6)
Menstrual Regulation
QHIST-10 / QHIST-5 (Northisterone) · ORMI-RIDE (Ormeloxifene 60mg)
Female Sexual Health
SINDRELA (Sildenafil 25mg Effervescent) · AL-GRO (L-Arginine + DHA + Proanthocyanidin)

Why Gynaecologists & IVF Specialists Choose Quinek

WHAT QUINEK OFFERS PRESCRIBING SPECIALISTS

WHO-GMP certified manufacturing — every formulation produced under internationally audited quality standards
Complete IVF cycle coverage — FSH, HMG, HCG, progesterone, estradiol, post-retrieval care from one certified partner
Multiple progesterone options — oral SR, vaginal gel, injectable and dydrogesterone — for individualised clinical management
Evidence-based formulations — product monographs, clinical literature and MoA references available for every key product
Consistent supply — reliable availability without stockouts or substitution, backed by GMP-compliant production planning

Why Distributors & Stockists Choose Quinek

The gynaecology and IVF pharma segment offers strong commercial opportunity — but only with the right certified partner. Distributors and C&F agents partnering with Quinek gain access to a portfolio that doctors ask for by name, backed by certifications that protect against regulatory exposure and quality incidents that can damage territory relationships built over years.

FOR DISTRIBUTION PARTNERS

Certified portfolio — WHO-GMP · GLP · ISO · DCGI · FSSAI across all products
Specialty focus — gynaecology and IVF are high-value, high-frequency prescription segments
Transparent terms — clear territory agreements, credit terms and marketing support
Supply reliability — consistent availability backed by compliant manufacturing capacity
Brand credibility — prescribers trust certified brands, making territory development faster

“Women’s health deserves pharmaceutical precision. Every formulation. Every cycle. Every patient.”

Quinek Life Sciences — WHO-GMP Certified Gynaecology & IVF Pharma Company, India

References & Further Reading

  1. WHO — 1 in 6 People Globally Affected by Infertility, 2023
  2. NCBI — Infertility Burden in India
  3. NCBI — PCOS Prevalence in Indian Women
  4. WHO — Good Manufacturing Practices for Pharmaceuticals
  5. Quinek Life Sciences — Gynaecology Segment
  6. Quinek Life Sciences — IVF & Fertility Segment
  7. Quinek Life Sciences — Quality Certifications

This article is for educational and informational purposes. All products mentioned are prescription medicines for professional use only. Quinek Life Sciences holds valid WHO-GMP, GLP, ISO, DCGI and FSSAI certifications at the time of publication.